Publications

APCaRI > Blog > Publications
Application of Surface-Enhanced Raman Spectroscopy to Guide Therapy for Advanced Prostate Cancer Patients

Analysis of the role of PI3K-AKT and DNA damage repair (DDR) genomic biomarkers as predictors of clinical outcomes in nonmetastatic castration-resistant prostate cancer (nmCRPC)

A prostate cancer risk calculator (PCRC-MRI): Use of clinical and magnetic resonance imaging data to predict biopsy outcome in North American men

Adam Kinnaird, MD PhD FRCSC

Important Features Identification for Prostate Cancer Patients Stratification Using Isolation Forest and Interactive Clustering Method

Predictive genomic biomarkers in non-metastatic castration resistant prostate cancer (nmCRPC) treated with androgen receptor pathway inhibitors (ARPi)

Cohort profile: APCaRI Registry and Biorepository facilitates technology translation to the clinic through the use of linked, longitudinal clinical and patient-reported data and biospecimens from men in Alberta, Canada

Catalina Vasquez MSc., C. Mgr. | Bryan Donnelly, MD, MSc, FRCSC | Eric Hyndman, MD, PhD | Adrian Fairey, MD | Dean Ruether, MD FRCSC | Jackson Wu, MSc, MD, FRCP | Michael Chetner, MD, MSc, FRCSC, FACS | Trafford Crump, PhD | Peter Venner, MD, FRCPC | Nawaid Usmani, MD, FRCPC | Gerald Todd, MD FRCS(c) DABU | John D. Lewis Research Group

Detection of EV-based signatures in prostate cancer using microflow cytometry and machine learning [abstract]

Evaluating the measurement properties of the 26-item Expanded Prostate Cancer Index Composite (EPIC-26) with a multicenter cohort

A Cluster-Based Machine Learning Model for Large Healthcare Data Analysis [abstract]

Small cell-like glandular proliferation of prostate: A rare lesion not related to small cell prostate cancer

Kiril Trpkov, MD, FRCPC

Malakoplakia associated with prostatic adenocarcinoma: Report of 4 cases and literature review

Kiril Trpkov, MD, FRCPC

Prostate Cancer after Initial High-Grade Prostatic Intraepithelial Neoplasia and Benign Prostate Biopsy

Kiril Trpkov, MD, FRCPC | Bryan Donnelly, MD, MSc, FRCSC

Quantitative Analysis of human Cancer Cell Extravasation Using Intravital Imaging

Lian Willetts, PhD | David Bond, PhD | Konstantin Stoletov, PhD | John D. Lewis Research Group

Ankyrin G expression is associated with androgen receptor stability, invasiveness, and lethal outcome in prostate cancer patients.

Tarek Bismar Research Group | John D. Lewis Research Group | Bryan Donnelly, MD, MSc, FRCSC

Multimodality Raman and photoacoustic imaging of surface-enhanced-Raman-scattering-targeted tumor cells

Robert Paproski, PhD | John D. Lewis Research Group

Enhanced Detection of Cancer Biomarkers in Blood-Borne Extracellular Vesicles Using Nanodroplets and Focused Ultrasound

Robert Paproski, PhD | Juan Jovel, PhD | John D. Lewis Research Group

Automated radiosynthesis of no-carrier-added 4-[18F]fluoroiodobenzene: a versatile building block in 18F radiochemistry.

Frank Wuest Research Group

Identification of Hepatotropic Viruses from Plasma Using Deep Sequencing: A Next Generation Diagnostic Tool

Gane Ka-Shu Wong Research Group | Eric John Carpenter | Glenn Ford | Jordan Dacey Lee Patterson | Sandra Lynn O'Keefe | Tracy Nicole Jordan | Troy Anthony Mitchell | Weiwei Wang, PhD

Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy.

Geoffrey Gotto, MD

The Future of NMR Metabolomics in Cancer Therapy: Towards Personalizing Treatment and Developing Targeted Drugs?

Hans Vogel Research Group

Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy.

Nawaid Usmani, MD, FRCPC | Sunita Ghosh, PhD

CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update

Nawaid Usmani, MD, FRCPC | Scott North, MD, FRCPC, MHPE

Detection of circulating tumor cells using targeted surface-enhanced Raman scattering nanoparticles and magnetic enrichment

Robert Paproski, PhD | Ronald Moore Research Group

Reporting and analyzing alternative clustering solutions by employing multi-objective genetic algorithm and conducting experiments on cancer data

Reda Alhajj, PhD | Mohamad Elzohbi | Peter Peng

Intermittent versus continuous androgen deprivation in prostate cancer.

Bryan Donnelly, MD, MSc, FRCSC | Peter Venner, MD, FRCPC

Next-generation Sequencing of Urologic Cancers: Next Is Now

Paul Boutros, PhD

Comparison of low and intermediate source strengths for (125)I prostate brachytherapy implants.

Nawaid Usmani, MD, FRCPC | Sunita Ghosh, PhD

Mentors and the butterfly effect: triggers for discovering signalling by proteinases via proteinase-activated receptors (PARs) and more.

Morley Hollenberg Research Group

Furthering the prostate cancer screening debate (prostate cancer specific mortality and associated risks).

Bryan Donnelly, MD, MSc, FRCSC | Dean Ruether, MD FRCSC | Michael Chetner, MD, MSc, FRCSC, FACS | Peter Venner, MD, FRCPC

Analysis of intraprostatic therapeutic effects in prostate cancer patients using [(11)C]-choline pet/ct after external-beam radiation therapy.

Melinda Wuest, PhD | Matthew Parliament, MD, FRCPC | Nawaid Usmani, MD, FRCPC

Conditional relative survival: a different perspective to measuring cancer outcomes.

Lorraine Shack, PhD

ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease.

Bryan Donnelly, MD, MSc, FRCSC | Kiril Trpkov, MD, FRCPC | Tarek Bismar Research Group

Sedentary Behavior and Prostate Cancer Risk in the NIH-AARP Diet and Health Study

Karen A. Kopciuk, PhD

Comparing efficiency of micro-RNA and mRNA biomarker liberation with microbubble-enhanced ultrasound exposure.

Robert Paproski, PhD

Tumor vascular responses to antivascular and antiangiogenic strategies: looking for suitable models

Jihane Mriouah, PhD

Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery.

Andries Zijlstra Research Group | John D. Lewis Research Group | Desmond Pink, PhD

Metastasis as a therapeutic target in prostate cancer: a conceptual framework

Andries Zijlstra Research Group | Katie Hebron | John D. Lewis Research Group | David Bond, PhD | Konstantin Stoletov, PhD | Srijan Raha

Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial

Jackson Wu, MSc, MD, FRCP

Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells

Jack Tuszynski Research Group

Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomy

Eric Hyndman, MD, PhD

Promoting consultation recording practice in oncology: identification of critical implementation factors and determination of patient benefit.

Dean Ruether, MD FRCSC

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

David Broadhurst, PhD

The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy

Bryan Donnelly, MD, MSc, FRCSC | Tarek Bismar Research Group

Invadopodia Are Required for Cancer Cell Extravasation and Are a Therapeutic Target for Metastasis

John D. Lewis Research Group | Katia Carmine-Simmen, PhD | Konstantin Stoletov, PhD

Integrin-Free Tetraspanin CD151 Can Inhibit Tumor Cell Motility upon Clustering and Is a Clinical Indicator of Prostate Cancer Progression

John D. Lewis Research Group

The Bird Dogs: Pointing for the Prostate Cancer Cure

For years, Frank Sojonky hid his battle with prostate cancer from the world. But by 2004 he could hide it no longer, as the disease metastasized and began to spread. So when he learned from his oncologist, Dr. Peter Venner, that a chair in prostate cancer research was needed in Alberta, he made his personal goal to raise the funds to do it. That is how the Bird Dogs started and thanks to them and the Alberta Cancer Foundation, Dr. John Lewis and the Alberta Prostate Cancer Research Initiative are making important discoveries to improve the lives of those with prostate cancer.

Watch a video about the Bird Dogs.

- APCaRI